We are live on ! Find out more
MED icon

Medifast

225 hedge funds and large institutions have $1,000M invested in Medifast in 2018 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 66 increasing their positions, 75 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 23

36% more capital invested

Capital invested by funds: $736M → $1,000M (+$264M)

22% more call options, than puts

Call options by funds: $6.71M | Put options by funds: $5.52M

12% more funds holding

Funds holding: 201225 (+24)

0.49% more ownership

Funds ownership: 88.36%88.85% (+0.49%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

12% less repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 75

Holders
225
Holders Change
+24
Holders Change %
+11.94%
% of All Funds
5.16%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
49
Increased
66
Reduced
75
Closed
23
Calls
$6.71M
Puts
$5.52M
Net Calls
+$1.19M
Net Calls Change
-$477K
Name Holding Trade Value Shares
Change
Change in
Stake
GLA
51
Great Lakes Advisors
Illinois
$3.6M +$2.88M +38,542 New
OAM
52
Oxford Asset Management
United Kingdom
$3.58M -$3.01M -40,288 -51%
TD Asset Management
53
TD Asset Management
Ontario, Canada
$3.48M +$14.9K +200 +0.5%
MC
54
Maverick Capital
Texas
$3.47M +$2.78M +37,160 New
QI
55
QS Investors
New York
$3.44M -$175K -2,346 -6%
AL
56
AJO LP
Pennsylvania
$3.34M -$3.21K -43 -0.1%
CCM
57
Cadence Capital Management
Massachusetts
$2.99M +$121K +1,621 +5%
Los Angeles Capital Management
58
Los Angeles Capital Management
California
$2.91M +$285K +3,815 +14%
MA
59
MYDA Advisors
New York
$2.65M +$2.11M +28,300 New
LCM
60
Landscape Capital Management
New Jersey
$2.53M +$2.02M +27,051 New
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
$2.36M +$25.2K +337 +1%
Squarepoint
62
Squarepoint
New York
$2.29M +$1.57M +20,948 +582%
SCP
63
Seizert Capital Partners
Michigan
$2.2M -$2.02M -27,028 -53%
Citadel Advisors
64
Citadel Advisors
Florida
$2.16M -$7.25K -97 -0.4%
Brown Advisory
65
Brown Advisory
Maryland
$2.15M +$589K +7,880 +52%
EGM
66
Engineers Gate Manager
New York
$2.08M +$1.66M +22,205 New
ARTA
67
A.R.T. Advisors
New York
$2.04M +$1.63M +21,848 New
HIM
68
Hillsdale Investment Management
Ontario, Canada
$2M
KBC Group
69
KBC Group
Belgium
$1.89M
FIM
70
Freedom Investment Management
Connecticut
$1.86M -$33.3K -445 -2%
Legal & General Group
71
Legal & General Group
United Kingdom
$1.83M +$54.4K +728 +4%
OCM
72
Osterweis Capital Management
California
$1.83M +$1.46M +19,550 New
AIM
73
Assured Investment Management
New York
$1.81M +$1.45M +19,348 New
VOYA Investment Management
74
VOYA Investment Management
Georgia
$1.75M
AllianceBernstein
75
AllianceBernstein
Tennessee
$1.71M +$450K +6,025 +49%

MED Hedge Fund Activity: Q1 2018 in Review

225 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q1 2018, worth a combined $1,000M — up 36% from $736M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new MED positions and 23 closed out — a net gain of 26 holders — while 66 added to existing stakes and 75 trimmed.

The largest buyer was Marshall Wace North America, adding an estimated $8.85M. The largest seller was Engaged Capital, exiting entirely with an estimated $18.5M sold.

  • 225 institutional investors held Medifast (MED) as of Q1 2018, up from 201 in Q4 2017.
  • Funds reported $1,000M of Medifast stock for Q1 2018, up 36% quarter-over-quarter.
  • 49 funds opened new Medifast positions in Q1 2018 and 23 closed out, a net change of +26 holders.
  • The largest Medifast buyer in Q1 2018 was Marshall Wace North America, an estimated $8.85M added.
  • The largest Medifast seller in Q1 2018 was Engaged Capital, an estimated $18.5M sold.

Based on aggregated 13F filings for Q1 2018.